Quantify

AbbVie Inc. vs Pfizer, Inc. — Stock Comparison

AbbVie Inc. (ABBV) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

vs
Q·Score Winner
Pfizer, Inc.
PFE6.2/10vs 5.8/10

Pfizer, Inc. narrowly edges AbbVie Inc. on Q·Score (6.2 vs 5.8 out of 10), led by Health (7 vs 4.3) and Quality (6.4 vs 5.8). AbbVie Inc. scores higher on Sentiment, reflecting stronger analyst and market sentiment. Analyst consensus targets imply greater upside for ABBV (+12.6%) than for PFE (+11.1%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
● ABBV● PFE

Q·Score Breakdown

5.8
Neutral
Overall
6.2
Neutral
5.8
Quality
6.4
4.3
Health
7
5.1
Growth
5.1
6.7
Valuation
7
7.7
Sentiment
5.3
ABBV

75% of 32 covering analysts have a positive rating.

⚠ balance sheet warrants attention.

PFE

Consistently beats earnings estimates (4/4 quarters).

⚠ earnings contracting 10% year-over-year.

Analyst Consensus

Bullish
+12.6%
Target $253.55
29 analysts
Neutral
+11.1%
Target $29.19
27 analysts

Fundamentals

ABBV
PFE
109.8×
Trailing P/E
20.1×
13.8×
Forward P/E
9.3×
5.79%
Profit Margin
11.83%
72.03%
Gross Margin
74.80%
—
ROE
8.31%
12.40%
Revenue Growth
5.40%
-46.20%
Earnings Growth
-10.10%
0.31
Beta
0.29
3.08%
Dividend Yield
6.57%
$397.7B
Market Cap
$149.8B
52-Week Range
ABBV
$18269% of range$245
PFE
$2356% of range$29

Frequently Asked Questions

ABBV vs PFE: which stock scores better overall?

Based on Q·Score, Pfizer, Inc. (PFE) scores 6.2/10 versus AbbVie Inc. (ABBV) at 5.8/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: ABBV or PFE?

AbbVie Inc. (ABBV) scores higher on Growth (5.1/10 vs 5.1/10). AbbVie Inc. reports revenue growth (12.4% YoY) while Pfizer, Inc. reports (5.4% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is ABBV or PFE more attractively valued?

Pfizer, Inc. (PFE) scores higher on Valuation (7/10 vs 6.7/10). ABBV trades at 13.8× P/E versus PFE at 9.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about ABBV vs PFE?

There are 29 analysts covering ABBV with a consensus price target of $253.55, and 27 analysts covering PFE with a consensus target of $29.19. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: ABBV or PFE?

Pfizer, Inc. (PFE) scores higher on Quality (6.4/10 vs 5.8/10). Net profit margin: ABBV at 5.8%, PFE at 11.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: ABBV or PFE?

Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 4.3/10). Market beta: ABBV at 0.31, PFE at 0.29. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of ABBV and PFE?

AbbVie Inc. (ABBV) has a market capitalisation of $397.7B, while Pfizer, Inc. (PFE) has a market cap of $149.8B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do ABBV or PFE pay dividends?

ABBV pays a dividend yield of 3.08%, while PFE pays a dividend yield of 6.57%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFEABBV vs MRKMRNA vs PFEABBV vs LLYABBV vs JNJLLY vs PFE

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026